Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Essent Biologics provides human primary cells, tissues, and scaffolds for research and manufacturing, with critical applications in regenerative medicine, drug testing, and 3D bioprinting. Products are manufactured under cGMP and distributed globally. The company enables development of therapies by supplying high-quality, low-passaged primary cells, including unique placental cell types, and has key partnerships facilitating cutting-edge research. No therapeutic clinical trials of in-house products are registered; the business focuses on supplying materials and data for clinical/preclinical R&D.[1][2][3][4][5][6][7][8]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Essent Biologics.